Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | EG-70 |
| Trade Name | |
| Synonyms | EG 70|EG70|Detalimogene voraplasmid |
| Drug Descriptions |
EG-70 consists of a DNA vector engineered to express interleukin-12 (IL-12) and a retinoic acid-inducible gene I protein (RIG-I; DDX58) activator in a nanoparticle-based formulation, which leads to increased levels of IL-12, and potentially results in activation of an antitumor immune response (Urologic Oncology, 42, Supplement, 2024, S48). |
| DrugClasses | |
| CAS Registry Number | 2660044-23-3 |
| NCIT ID | C179685 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| EG-70 | EG-70 | 0 | 1 |